Seifert, Georg http://orcid.org/0000-0002-7109-9277
Blakeslee, Sarah B.
Calaminus, Gabriele
Kandil, Farid I.
Barth, Andrea
Bernig, Toralf
Classen, Carl Friedrich
Corbacioglu, Selim
Föll, Jürgen
Gottschling, Sven
Gruhn, Bernd
vom Hoff-Heise, Claudia
Lode, Holger N.
Martin, David
Nathrath, Michaela
Neunhoeffer, Felix
Pekrun, Arnulf
Wulff, Beate
Zuzak, Tycho
Henze, Günter
Längler, Alfred
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 26 January 2022
Accepted: 24 May 2022
First Online: 13 June 2022
Declarations
:
: The authors declare no competing interests. The trial was approved by the Institutional Review Board of Charité - Universitätsmedizin Berlin as the responsible ethics committee (EA2/141/05). Prior to the trial commencement, the study was registered at the European Union (EU) Drug Clinical Trials Register (EudraCT- No: 2004–002711-83). Furthermore, all participants provided written informed consent in accordance to the Declaration of Helsinki.
: This manuscript contains no individual data needing additional consent and is therefore not applicable.
: None of the authors have competing interests to declare.